Pipeline

TheraVet focuses on the development of effective treatments for orthopedic and osteoarticular indications. By developing unique solutions, our commitment is to improve the level of care allowing companion animals to live healthier. In order to fully meet the veterinarian needs, TheraVet’s goal is to provide local – safe & effective - treatments with superior ergonomics.

TheraVet has expertise in the development of veterinary products from formulation to production through preclinical, clinical and regulatory evaluation.

TheraVet currently has two product lines in development:

• BIOCERA-VET: a line of injectable self-hardening phosphocalcic bone void fillers with enhanced osteointegration, osteoinduction and bone remodeling properties

• VISCO-VET: a versatile line of intra-articular injectable gel based on hyaluronic acid, species specific plasma and an active pharmaceutical component

TheraVet is constantly working on enlarging its already existing product lines and has therefore other unique solutions in its pipeline. 

Warning: VISCO-VET is a veterinary medicinal product under investigation that did not receive yet a market authorization. VISCO-VET is therefore not available for sale.